Overview
AMPH market data
Price History
AMPH price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for AMPH. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Two Years to Build or Pay 200% — Which US Pharma Stocks Win?Benzinga · Jul 24, 2026, 10:25 AM
Shares of generic drug companies are trading lower after President Trump announced that imported generics will be subject to a 100% import tariff following a two-year grace period in order to encourage reshoring of pharma manufacturing.Benzinga · Jul 22, 2026, 4:27 PM
8-K filing — Amphastar Pharmaceuticals, Inc. (AMPH)SEC EDGAR · Jul 13, 2026, 10:01 AM
WHO Director-General Ghebreyesus Says He Considers The Cruise Ship-Linked Hantavirus Outbreak To Be OverBenzinga · Jul 2, 2026, 1:25 PM
Crude Oil Gains 2%; Comcast Shares Spike HigherBenzinga · Jun 29, 2026, 4:35 PM
This Liquidia Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For MondayBenzinga · Jun 29, 2026, 12:50 PM
B of A Securities Downgrades Amphastar Pharma to Underperform, Lowers Price Target to $20Benzinga · Jun 29, 2026, 12:00 PM
This Whirlpool Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For ThursdayBenzinga · May 14, 2026, 12:47 PM
Wells Fargo Downgrades Amphastar Pharma to Equal-Weight, Lowers Price Target to $19Benzinga · May 14, 2026, 12:37 PM